Validity of the Montreal Cognitive Assessment (MoCA) as a screening test for Mild Cognitive Impairment (MCI) in a cardiovascular population

Journal of Geriatric Psychiatry and Neurology

Volumn 24, Issue 1, 2011, Pages 33-38

  McLennan, S N ^a   Mathias, J L ^a   Brennan, L C ^b   Stewart, S ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

cardiovascular; MCI; mild cognitive impairment; MoCA; Montreal Cognitive Assessment; vascular cognitive impairment; vascular dementia

Indexed keywords

ADULT; AGED; ARTICLE; ATTENTION; CARDIAC PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MONTREAL COGNITIVE ASSESSMENT; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL ASSESSMENT BATTERY SCREENING MODULE; NEUROPSYCHOLOGICAL TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING; SENSITIVITY AND SPECIFICITY; VISUAL MEMORY; WORKING MEMORY;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MASS SCREENING; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 79951867585     PISSN: 08919887     EISSN: 15525708     Source Type: Journal    
DOI: 10.1177/0891988710390813     Document Type: Article

References (30)

1. Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet. 2006;367(9518):1262-1270.
2. Mariani E, Monastero R, Mecocci P. Mild cognitive impairment: a systematic review. J Alzheimers Dis. 2007;12(1):23-35. (Pubitemid 47396302)
3. Mariani E, Monastero R, Ercolani S, et al. Influence of comorbidity and cognitive status on instrumental activities of daily living in amnestic mild cognitive impairment: results from the ReGA1 project. Int J Geriatr Psychiatry. 2008;23(5):523-530. (Pubitemid 351722113)
4. Pereira FS, Yassuda MS, Oliveira AM, Forlenza OV. Executive dysfunction correlates with impaired functional status in older adults with varying degrees of cognitive impairment. Int Psychogeriatr. 2008;20(6):1104-1115.
5. Kim KR, Lee KS, Cheong HK, Eom JS, Oh BH, Hong CH. Characteristic profiles of instrumental activities of daily living in different subtypes of Mild Cognitive Impairment. Dement Geriatr Cogn Disord. 2009;27(3):278-285.
6. Panza F, D'Introno A, Colacicco AM, et al. Current epidemiology of mild cognitive impairment and other predementia syndromes. Am J Geriatr Psychiatry. 2005;13(8):633-644. (Pubitemid 41197234)
7. Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the cardiovascular health study. Arch Gen Psychiatry. 2006;63(3):273-279.
8. Kivipelto M, Helkala EL, Hanninen T, et al. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology. 2001;56(12):1683-1689. (Pubitemid 32574567)
9. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment (MoCA): a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699. (Pubitemid 41623495)
10. Lonie JA, Tierney KM, Ebmeier KP. Screening for mild cognitive impairment: a systematic review. Int J Geriatr Psychiatry. 2009;24(9):902-915.
11. Zanetti M, Ballabio C, Abbate C, Cutaia C, Vergani C, Bergamaschini L. Mild cognitive impairment subtypes and vascular dementia in community-dwelling elderly people: a 3-year follow-up study. J Am Geriatr Soc. 2006;54(4):580-586.
12. Nordlund A, Rolstad S, Klang O, Lind K. Cognitive profiles of mild cognitive impairment with and without vascular disease. Neuropsychology. 2007;21(6):706-712. (Pubitemid 350116514)
13. Ingles JL, Boulton DC, Fisk JD, Rockwood K. Preclinical vascular cognitive impairment and Alzheimer disease: neuropsychological test performance 5 years before diagnosis. Stroke. 2007;38(4):1148-1153. (Pubitemid 351664251)
14. Smith T, Gildeh N, Holmes C. The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. Can J Psychiatry. 2007;52(5):329-332. (Pubitemid 46743462)
15. Luis CA, Keegan AP, Mullan M. Cross validation of the Montreal Cognitive Assessment in community dwelling adults residing in the Southeastern US. Int J Geriatr Psychiatry. 2009;24(2):197-201.
16. Alexopoulos P, Grimmer T, Perneczky R, Domes G, Kurz A. Progression to dementia in clinical subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord. 2006;22(1):27-34.
17. Di Carlo A, Lamassa M, Baldereschi M, et al. CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia. Neurology. 2007;68(22):1909-1916. (Pubitemid 46848623)
18. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914-919.
19. Stern RA, White T. Neuropsychological Assessment Battery: Administration, Scoring, and Interpretation Manual. Lutz, FL: Psychological Assessment Resources; 2003.
20. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303-308. (Pubitemid 29120227)
21. Busse A, Bischkopf J, Riedel-Heller SG, Angermeyer MC. Sub-classifications for mild cognitive impairment: prevalence and predictive validity. Psychol Med. 2003;33(6):1029-1038. (Pubitemid 37009821)
22. Lee JY, Dong Woo L, Cho SJ, et al. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment. J Geriatr Psychiatry Neurol. 2008;21(2):104-110. (Pubitemid 351677877)
23. Shulman KI, Herrmann N, Brodaty H, et al. IPA survey of brief cognitive screening instruments. Int Psychogeriatr. 2006;18(2):281-294. (Pubitemid 43829878)
24. Rami L, Gómez-Anson B, Sanchez-Valle R, et al. Longitudinal study of amnesic patients at high risk for Alzheimer's disease: clinical, neuropsychological and magnetic resonance spectroscopy features. Dement Geriatr Cogn Disord. 2007;24(5):402-410. (Pubitemid 350036698)
25. Pyo G, Elble RJ, Ala T, Markwell SJ. The characteristics of patients with uncertain/mild cognitive impairment on the Alzheimer's disease assessment scale-cognitive subscale. Alzheimer Dis Assoc Disord. 2006;20(1):16-22.
26. Chandler MJ, Lacritz LH, Hynan LS, et al. A total score for the CERAD neuropsychological battery. Neurology. 2005; 65(1):102-106.
27. Hayden KM, Warren LH, Pieper CF, et al. Identification of VaD and AD prodromes: the Cache County Study. Alzheimers Dement. 2005;1(1):19-29. (Pubitemid 43348850)
28. Waite LM, Broe GA, Grayson DA, Creasey H. Preclinical syndromes predict dementia: the Sydney older persons study. J Neurol Neurosurg Psychiatry. 2001;71(3):296-302. (Pubitemid 32772524)
29. O'Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol. 2003;2(2):89-98. (Pubitemid 37443329)
30. Popovic IM, Seric V, Demarin V. Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease. J Neurol Sci. 2007;257(1-2):185-193. (Pubitemid 46856505)